Brain cancer
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
137
NCT04205227
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 18, 2020
Completion: Mar 31, 2026
Loading map...